Skip to content

Investigation of Stem Cells in Human Lipoaspirate

Investigation of Adipose-Derived Stem Cells in Human Lipoaspirate

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01677520
Enrollment
240
Registered
2012-09-03
Start date
2011-03-31
Completion date
2018-08-31
Last updated
2015-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

adipose-derived stem cells, viable ADSCs, apoptosis, necrosis, cryopreservation

Brief summary

The overall purpose of this study is to enhance identification and isolation of ADSCs and adipocytes, to find the optimum culturing conditions to increase growth and volume of grafts, and to study the effects of cryopreservation on ADSCs and adipocytes. Fat injections are used in aesthetic surgery but tend to disassemble over time. If the investigators can enhance growth and volume of fat in culture, the investigators could use fat grafts in reconstruction of cancer and traumatic injury defects with the patients own cultured fat cells and grafts.

Interventions

None listed

Sponsors

University of Nevada, Las Vegas
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* All adults (18-70 yrs) who have scheduled surgical lipectomy of the hips, abdomen, or thighs are prospective subjects for this study.

Exclusion criteria

* Pregnant women will be excluded to protect the unborn child.

Design outcomes

Primary

MeasureTime frameDescription
Percent of Viable ADSCsDay of SurgeryPercent of viable ADSCs will be measured on fresh samples and samples refrigerated for different times.

Secondary

MeasureTime frameDescription
Percent of Apoptotic ADSCsDay of SurgeryPercent of apoptotic ADSCs will be measured on fresh samples and on refrigerated samples at 1, 2, 3, and 4 days refrigerated storage.

Other

MeasureTime frameDescription
Percent of Necrotic ADSCsDay of SurgeryPercent of necrotic ADSCs will be measured on fresh samples and on refrigerated samples at 1, 2, 3, and 4 days of refrigerated storage.

Countries

United States

Contacts

Primary ContactWilliam A Zamboni, M.D.
wzamboni@medicine.nevada.edu702-671-2278
Backup ContactShelley J Williams, M.S.
sjwilliams@medicine.nevada.edu702-895-1445

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026